Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Crohn disease (CD) and ulcerative colitis (UC) are increasingly common, chronic forms of inflammatory bowel disease. The behavior of these diseases varies unpredictably among patients. Identification of reliable prognostic biomarkers would enable treatment to be personalized so that patients destined to experience aggressive disease could receive appropriately potent therapies from diagnosis, while those who will experience more indolent disease are not exposed to the risks and side effects of unnecessary immunosuppression. Using transcriptional profiling of circulating T cells isolated from patients with CD and UC, we identified analogous CD8+ T cell transcriptional signatures that divided patients into 2 otherwise indistinguishable subgroups. In both UC and CD, patients in these subgroups subsequently experienced very different disease courses. A substantially higher incidence of frequently relapsing disease was experienced by those patients in the subgroup defined by elevated expression of genes involved in antigen-dependent T cell responses, including signaling initiated by both IL-7 and TCR ligation - pathways previously associated with prognosis in unrelated autoimmune diseases. No equivalent correlation was observed with CD4+ T cell gene expression. This suggests that the course of otherwise distinct autoimmune and inflammatory conditions may be influenced by common pathways and identifies what we believe to be the first biomarker that can predict prognosis in both UC and CD from diagnosis, a major step toward personalized therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CTLs are emerging as major mediators of human IBD, which is also prognostically linked to CTL profiling.31”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Adjusting batch effects in microarray expression data using empirical Bayes methods
Johnson, W. E., Li, C., & Rabinovic, A. (2007) · Biostatistics · doi:10.1093/biostatistics/kxj037 · Cited by 8,658
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J.-F., Gasche, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,409
Huber, W., von Heydebreck, A., Sültmann, H., Poustka, A., & Vingron, M. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.suppl_1.s96 · Cited by 2,440
Research works printed but not linked: 2
- Fagan, 1975, N Engl J Med., 293, 257
- Muller, 1998, Am J Pathol., 152, 261
Cited by
Torres, J., Mehandru, S., Colombel, J.-F., & Peyrin-Biroulet, L. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31711-1 · Cited by 2,682
Lamb, C. A., Kennedy, N. A., Raine, T., Hendy, P. A., Smith, P. J., Limdi, J. K., Hayee, B., Lomer, M. C. E., Parkes, G. C., Selinger, C., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318484 · Cited by 2,346
Self-citationSun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,014
T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection
McKinney, E. F., Lee, J. C., Jayne, D. R. W., Lyons, P. A., & Smith, K. G. C. (2015) · Nature · doi:10.1038/nature14468 · Cited by 685
Self-citationDolinger, M., Torres, J., & Vermeire, S. (2024) · The Lancet · doi:10.1016/s0140-6736(23)02586-2 · Cited by 580
Wang, L., Tang, L., Feng, Y., Zhao, S., Han, M., Zhang, C., Yuan, G., Zhu, J., Cao, S., Wu, Q., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-320105 · Cited by 630
Genetics of Inflammatory Bowel Diseases
McGovern, D. P. B., Kugathasan, S., & Cho, J. H. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.001 · Cited by 431
Microbial network disturbances in relapsing refractory Crohn’s disease
Swiss IBD Cohort Investigators, Yilmaz, B., Juillerat, P., Øyås, O., Ramon, C., Bravo, F. D., Franc, Y., Fournier, N., Michetti, P., Mueller, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0308-z · Cited by 428
Noor, N. M., Lee, J. C., Bond, S., Dowling, F., Brezina, B., Patel, K. V., Ahmad, T., Banim, P. J., Berrill, J. W., Cooney, R., et al. (2024) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(24)00034-7 · Cited by 310
Self-citationUlcerative colitis: Recent advances in the understanding of disease pathogenesis
Porter, R. J., Kalla, R., & Ho, G.-T. (2020) · F1000Research · doi:10.12688/f1000research.20805.1 · Cited by 300
Management Strategies to Improve Outcomes of Patients With Inflammatory Bowel Diseases
Colombel, J.-F., Narula, N., & Peyrin-Biroulet, L. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.09.046 · Cited by 299
Single-cell atlas of colonic CD8+ T cells in ulcerative colitis
Corridoni, D., Antanaviciute, A., Gupta, T., Fawkner-Corbett, D., Aulicino, A., Jagielowicz, M., Parikh, K., Repapi, E., Taylor, S., Ishikawa, D., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1003-4 · Cited by 252
Ventham, N. T., Kennedy, N. A., Adams, A. T., Kalla, R., Heath, S., O'Leary, K. R., Drummond, H., IBD BIOM consortium, Lauc, G., Campbell, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms13507 · Cited by 255
Lee, J. C., Espéli, M., Anderson, C. A., Linterman, M. A., Pocock, J. M., Williams, N. J., Roberts, R., Viatte, S., Fu, B., Peshu, N., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.034 · Cited by 231
Self-citationBig data in IBD: big progress for clinical practice
Seyed Tabib, N. S., Madgwick, M., Sudhakar, P., Verstockt, B., Korcsmaros, T., & Vermeire, S. (2020) · Gut · doi:10.1136/gutjnl-2019-320065 · Cited by 223
Biomarkers in inflammatory bowel disease: current practices and recent advances.
Iskandar, H. N., & Ciorba, M. A. (2012) · Translational Research · doi:10.1016/j.trsl.2012.01.001 · Cited by 210
A blood-based prognostic biomarker in IBD
Biasci, D., Lee, J. C., Noor, N. M., Pombal, D. R., Hou, M., Lewis, N., Ahmad, T., Hart, A., Parkes, M., McKinney, E. F., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318343 · Cited by 190
Self-citationGenetics of inflammatory bowel disease: beyond NOD2
Mirkov, M. U., Verstockt, B., & Cleynen, I. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30111-x · Cited by 171
Translating Immunology into Therapeutic Concepts for Inflammatory Bowel Disease
Uhlig, H. H., & Powrie, F. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053055 · Cited by 169
Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases
Sandborn, W. J., Hanauer, S., Van Assche, G., Panés, J., Wilson, S., Petersson, J., & Panaccione, R. (2014) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2014.02.021 · Cited by 158
Funderburg, N. T., Stubblefield Park, S. R., Sung, H. C., Hardy, G., Clagett, B., Ignatz‐Hoover, J., Harding, C. V., Fu, P., Katz, J. A., Lederman, M. M., et al. (2013) · Immunology · doi:10.1111/imm.12114 · Cited by 152
Genetics and epigenetics of IBD
Annese, V. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104892 · Cited by 163
Ascierto, P. A., Kalos, M., Schaer, D. A., Callahan, M. K., & Wolchok, J. D. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2982 · Cited by 139
IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease
Belarif, L., Danger, R., Kermarrec, L., Nerrière-Daguin, V., Pengam, S., Durand, T., Mary, C., Kerdreux, E., Gauttier, V., Kucik, A., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci121668 · Cited by 138
Smids, C., Horje, C. S. H. T., Drylewicz, J., Roosenboom, B., Groenen, M. J. M., van Koolwijk, E., van Lochem, E. G., & Wahab, P. J. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx160 · Cited by 150
Serum Calprotectin: A Novel Diagnostic and Prognostic Marker in Inflammatory Bowel Diseases
Kalla, R., Kennedy, N. A., Ventham, N. T., Boyapati, R. K., Adams, A. T., Nimmo, E. R., Visconti, M. R., Drummond, H., Ho, G.-T., Pattenden, R. J., et al. (2016) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.342 · Cited by 124
Luo, Y., Lan, C., Li, H., Ouyang, Q., Kong, F., Wu, A., Ren, Z., Tian, G., Cai, J., Yu, B., et al. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00338-4 · Cited by 138
New Insights on CD8+ T Cells in Inflammatory Bowel Disease and Therapeutic Approaches
Casalegno‐Garduño, R., & Däbritz, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.738762 · Cited by 134
Aschenbrenner, D., Quaranta, M., Banerjee, S., Ilott, N., Jansen, J., Steere, B., Chen, Y.-H., Ho, S., Cox, K., Arancibia-Cárcamo, C. V., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321731 · Cited by 123
Redefining the IBDs using genome-scale molecular phenotyping
Furey, T. S., Sethupathy, P., & Sheikh, S. Z. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0118-x · Cited by 129
Pathogenesis of Crohn's disease
Boyapati, R. K., Satsangi, J. J., & Ho, G. (2015) · F1000Prime Reports · doi:10.12703/p7-44 · Cited by 148
Marsal, J., Acosta, M. B., Blumenstein, I., Cappello, M., Bazin, T., & Sebastian, S. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.897936 · Cited by 136
Cano-Gamez, E., Burnham, K. L., Goh, C., Allcock, A., Malick, Z. H., Overend, L., Kwok, A. J., Smith, D. A. B., Sengers, H. P., Antcliffe, D. B., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abq4433 · Cited by 117
Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis
Livanos, A. E., Dunn, A., Fischer, J., Ungaro, R. C., Turpin, W., Lee, S.-H., Rui, S., Valle, D. M. D., Jougon, J., Martínez-Delgado, G., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.12.042 · Cited by 120
Classification of inflammatory bowel disease: the old and the new
Vermeire, S., Assche, G. V., & Rutgeerts, P. J. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328354be1e · Cited by 106
Biomarkers in inflammatory bowel disease: a practical guide
Clough, J., Colwill, M., Poullis, A. P., Pollok, R., Patel, K., & Honap, S. (2024) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848241251600 · Cited by 118
Statistical Methods in Integrative Genomics
Richardson, S., Tseng, G. C., & Sun, W. (2016) · Annual Review of Statistics and Its Application · doi:10.1146/annurev-statistics-041715-033506 · Cited by 100
Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus
Danese, S., Allez, M., Bodegraven, A. A. V., Dotan, I., Gisbert, J. P., Hart, A. L., Lakatos, P. L., Magro, F., Peyrin‐Biroulet, L., Schreiber, S., et al. (2019) · Digestive Diseases · doi:10.1159/000496739 · Cited by 102
Bourgonje, A. R., Klóska, D., Grochot‐Przeczek, A., Feelisch, M., Cuadrado, A., & van Goor, H. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102603 · Cited by 105
Peters, J. E., Lyons, P. A., Lee, J. C., Richard, A. C., Fortune, M. D., Newcombe, P. J., Richardson, S., & Smith, K. G. C. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1005908 · Cited by 95
Self-citationUnderstanding Human Autoimmunity and Autoinflammation Through Transcriptomics
Banchereau, R., Cepika, A., Banchereau, J., & Pascual, V. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052225 · Cited by 121
Huang, F., Thokerunga, E., He, F., Zhu, X., Wang, Z., & Tu, J. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02613-1 · Cited by 97
Montero‐Melendez, T., Llor, X., García-Planella, E., Perretti, M., & Suárez, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076235 · Cited by 96
Challenges in IBD Research: Precision Medicine
Denson, L. A., Curran, M., McGovern, D. P. B., Koltun, W. A., Duerr, R. H., Kim, S. C., Sartor, R. B., Sylvester, F. A., Abraham, C., de Zoeten, E. F., et al. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz078 · Cited by 94
Nestor, C. E., Barrenäs, F., Wang, H., Lentini, A., Zhang, H., Bruhn, S., Jörnsten, R., Langston, M. A., Rogers, G., Gustafsson, M., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004059 · Cited by 92
“These findings are in line with those reported here (Figure 1B) and in numerous previous studies of CD4 T-cells in allergy and other autoimmune diseases [6,8,9].”
BackgroundResultPrecision medicine in inflammatory bowel disease: concept, progress and challenges
Borg-Bartolo, S. P., Boyapati, R. K., Satsangi, J., & Kalla, R. (2020) · F1000Research · doi:10.12688/f1000research.20928.1 · Cited by 90
De-escalation of immunomodulator and biological therapy in inflammatory bowel disease
Chapman, T., Gomes, C. F., Louis, E. J., Colombel, J., & Satsangi, J. (2019) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(19)30186-4 · Cited by 97
Bai, A., Moss, A., Rothweiler, S., Serena Longhi, M., Wu, Y., Junger, W. G., & Robson, S. C. (2015) · Nature Communications · doi:10.1038/ncomms9819 · Cited by 83
The immunopathology of ANCA-associated vasculitis
McKinney, E. F., Willcocks, L. C., Broecker, V., & Smith, K. G. C. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0436-6 · Cited by 95
Self-citationKalla, R., Adams, A. T., Bergemalm, D., Vatn, S., Kennedy, N. A., Ricanek, P., Lindstrom, J., Ocklind, A., Hjelm, F., Ventham, N. T., et al. (2021) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjaa230 · Cited by 80
Moving towards disease modification in inflammatory bowel disease therapy
Allen, P. B., & Peyrin‐Biroulet, L. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283622914 · Cited by 79
Verstockt, B., Bressler, B. L., Martínez-Lozano, H., McGovern, D. P. B., & Silverberg, M. S. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.12.246 · Cited by 86
Blankley, S., Berry, M. P. R., Graham, C. M., Bloom, C. I., Lipman, M. C. I., & O’Garra, A. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0427 · Cited by 84
Verstockt, B., Noor, N. M., Marigorta, U. M., Pavlidis, P., Deepak, P., Ungaro, R. C., Fiocchi, C., Torres, J., & Scharl, M. M. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab050 · Cited by 85
Expression quantitative trait locus analysis for translational medicine
Gibson, G. C., Powell, J. E., & Marigorta, U. M. (2015) · Genome Medicine · doi:10.1186/s13073-015-0186-7 · Cited by 85
CCR9 antagonism: potential in the treatment of Inflammatory Bowel Disease
Keshav, S., & Wendt, E. (2015) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s48305 · Cited by 71
Inflammatory bowel disease and psoriasis: modernizing the multidisciplinary approach
Hedin, C. R. H., Sonkoly, E., Eberhardson, M., & Ståhle, M. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13282 · Cited by 84
Mishra, N., Aden, K., Blase, J. I., Baran, N., Bordoni, D., Tran, F., Conrad, C. C., Avalos, D., Jaeckel, C., Scherer, M., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01112-z · Cited by 84
Self-citationInflammation, Autoinflammation and Autoimmunity in Inflammatory Bowel Diseases
Padoan, A., Musso, G., Contran, N., & Basso, D. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45070350 · Cited by 80
Personalising medicine in inflammatory bowel disease—current and future perspectives
Ashton, J. J., Mossotto, E., Ennis, S., & Beattie, R. M. (2019) · Translational Pediatrics · doi:10.21037/tp.2018.12.03 · Cited by 80
Epigenetics in asthma and COPD
Kabesch, M., & Adcock, I. M. (2012) · Biochimie · doi:10.1016/j.biochi.2012.07.017 · Cited by 81
Lamb, C. A., Saifuddin, A., Powell, N., & Rieder, F. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.09.077 · Cited by 72
Immune cell profiling to guide therapeutic decisions in rheumatic diseases
Ermann, J., Rao, D. A., Teslovich, N. C., Brenner, M. B., & Raychaudhuri, S. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.71 · Cited by 73
Early Diagnosis, Early Stratification, and Early Intervention to Deliver Precision Medicine in IBD
Noor, N. M., Sousa, P., Paul, S., & Roblin, X. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izab228 · Cited by 74
Omics and Multi-Omics in IBD: No Integration, No Breakthroughs
Fiocchi, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914912 · Cited by 68
Parkes, M., Noor, N. M., Dowling, F., Leung, H., Bond, S. J., Whitehead, L., Upponi, S. S., Kinnon, P., Sandham, A. P., Lyons, P. A., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-026767 · Cited by 70
Self-citationBlood-based signatures in type 1 diabetes
Cabrera, S. M., Chen, Y.-G., Hagopian, W., & Hessner, M. J. (2015) · Diabetologia · doi:10.1007/s00125-015-3843-x · Cited by 65
Towards personalized care in IBD
Gerich, M. E., & McGovern, D. P. B. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.242 · Cited by 66
Chatu, S. S., Saxena, S. K., Subramanian, V., Ćurčin, V., Yadegarfar, G., Gunn, L. H., Majeed, A., & Pollok, R. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.462 · Cited by 60
How Do We Predict a Patient’s Disease Course and Whether They Will Respond to Specific Treatments?
Verstockt, B., Parkes, M., & Lee, J. C. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.12.245 · Cited by 64
Self-citationVerstockt, S., Verstockt, B., & Vermeire, S. (2019) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2019.1677608 · Cited by 64
Gasparetto, M., Payne, F., Nayak, K., Kraiczy, J., Glemas, C., Philip-McKenzie, Y., Ross, A., Edgar, R. D., Zerbino, D. R., Salvestrini, C., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.08.017 · Cited by 62
Low Serum Levels of MicroRNA-19 Are Associated with a Stricturing Crohnʼs Disease Phenotype
Lewis, A., Mehta, S. J., Hanna, L. N., Rogalski, L. A., Jeffery, R. E., Nijhuis, A. M., Kumagai, T., Biancheri, P., Bundy, J. G., Bishop, C. L., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000443 · Cited by 59
Self-citationTumor Necrosis Factor Receptor 2 Restricts the Pathogenicity of CD8+ T Cells in Mice With Colitis
Punit, S., Dubé, P. E., Liu, C. Y., Girish, N., Washington, M. K., & Polk, D. B. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.004 · Cited by 60
Inflammatory Bowel Disease Through the Lens of Single-cell RNA-seq Technologies
Corridoni, D., Chapman, T., Antanaviciute, A., Satsangi, J. J., & Simmons, A. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa089 · Cited by 57
Biomarkers in Search of Precision Medicine in IBD
Boyapati, R. K., Kalla, R., Satsangi, J. J., & Ho, G. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.441 · Cited by 57
Swaminathan, A., Fan, D., Borichevsky, G. M., Mules, T. C., Hirschfeld, E., Frampton, C. M., Day, A. S., Siegel, C. A., & Gearry, R. B. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17058 · Cited by 60
Nowak, J. K., Adams, A. T., Kalla, R., Lindstrøm, J. C., Vatn, S., Bergemalm, D., Keita, Å. V., Gomollón, F., Jahnsen, J., Vatn, M. H., et al. (2022) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjac033 · Cited by 51
“75] UC extent E1 42 [25%] E2 54 [32%] E3 72 [43%] Mayo endoscopic subscore [n = 122] 4 [2-7] mean 4.”
Kalla, R., Adams, A. T., Nowak, J. K., Bergemalm, D., Vatn, S., Ventham, N. T., Kennedy, N. A., Ricanek, P., Lindstrøm, J. C., Andersson, E., et al. (2022) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjac127 · Cited by 56
Martin‐Gutierrez, L., Peng, J., Thompson, N. L., Robinson, G., Naja, M., Peckham, H., Wu, W.-H., J’bari, H., Ahwireng, N., Waddington, K. E., et al. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41708 · Cited by 54
Sudhakar, P., Verstockt, B., Cremer, J., Verstockt, S., Sabino, J., Ferrante, M., & Vermeire, S. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa281 · Cited by 49
“13 Nevertheless, a comprehensive analysis of molecular features that contributes to the vast panels of clinical heterogeneity from a systemic and network biology perspective has not been carried out.”
BackgroundKrzystek‐Korpacka, M., Zawadzki, M., Neubauer, K., Bednarz‐Misa, I., Górska, S., Wiśniewski, J. Ł., Witkiewicz, W., & Gamian, A. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1933-3 · Cited by 49
Boldison, J., Chu, C. J., Copland, D. A., Lait, P. J. P., Khera, T. K., Dick, A. D., & Nicholson, L. B. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301390 · Cited by 51
Dai, B., Hackney, J. A., Ichikawa, R., Nguyen, A., Elstrott, J., Orozco, L. D., Sun, K.-H., Modrusan, Z. D., Gogineni, A., Scherl, A., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100381 · Cited by 58
Vatn, S., Carstens, A., Kristoffersen, A. B., Bergemalm, D., Casèn, C., Moen, A. E. F., Tannæs, T. M., Lindstrøm, J. C., Detlie, T. E., Olbjørn, C., et al. (2020) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2020.1803396 · Cited by 50
Cross-presentation of IgG-containing immune complexes
Baker, K., Räth, T., Lencer, W. I., Fiebiger, E., & Blumberg, R. S. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1100-8 · Cited by 51
Novel CD8+ T-Cell Subsets Demonstrating Plasticity in Patients with Inflammatory Bowel Disease
Tom, M. R., Li, J., Ueno, A., Gasia, M. F., Chan, R., Hung, D. Y., Chenoo, S., Iacucci, M., Jijon, H. B., Kaplan, G. G., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000848 · Cited by 50
The Untapped Opportunity and Challenge of Immunometabolism: A New Paradigm for Drug Discovery
Mazumdar, C., Driggers, E. M., & Turka, L. A. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.014 · Cited by 50
Molecular Profiling of Inflammatory Bowel Disease: Is It Ready for Use in Clinical Decision-Making?
Lee, H., & Cleynen, I. (2019) · Cells · doi:10.3390/cells8060535 · Cited by 50
Corridoni, D., Chapman, T., Ambrose, T., & Simmons, A. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00032 · Cited by 49
Transcriptomic Analysis of CD4+ T Cells Reveals Novel Immune Signatures of Latent Tuberculosis
Burel, J. G., Arlehamn, C. S. L., Khan, N., Seumois, G., Greenbaum, J., Taplitz, R., Gilman, R. H., Saito, M., Vijayanand, P., Sette, A., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800118 · Cited by 53
Resolving mechanisms of immune‐mediated disease in primary CD4 T cells
Bourges, C., Groff, A. F., Burren, O. S., Gerhardinger, C., Mattioli, K., Hutchinson, A., Hu, T. X., Anand, T., Epping, M. W., Wallace, C., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012112 · Cited by 52
Self-citationShon, W.-J., Jung, M. H., Kim, Y.-H., Kang, G. H., Choi, E. Y., & Shin, D. (2022) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2022.109254 · Cited by 48
Identifying Patients With Inflammatory Bowel Diseases at High vs Low Risk of Complications
Siegel, C. A., & Bernstein, C. N. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.11.034 · Cited by 47
Zundler, S., & Neurath, M. F. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001067 · Cited by 49
Thomas, M. G., Bayliss, C., Bond, S. J., Dowling, F., Galea, J. P., Jairath, V., Lamb, C. A., Probert, C. S., Timperley-Preece, E., Watson, A. J. M., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-023765 · Cited by 43
Self-citationBoschetti, G., Nancey, S., Moussata, D., Cotte, E., François, Y., Flourié, B., & Kaiserlian, D. (2015) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjv211 · Cited by 42
Xu, Y., Zhu, W., & Guo, Z. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i48.6888 · Cited by 47
Kron, M. A., Metwali, A., Vodanovic-Jankovic, S., & Elliott, D. (2013) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00594-12 · Cited by 39
Recent advances: personalised use of current Crohn's disease therapeutic options
Vermeire, S., Ferrante, M., & Rutgeerts, P. J. (2013) · Gut · doi:10.1136/gutjnl-2012-303958 · Cited by 40
Metadata
- Authors
- Lee, J. C., Lyons, P. A., McKinney, E. F., Sowerby, J. M., Carr, E. J., Bredin, F., Rickman, H. M., Ratlamwala, H., Hatton, A., Rayner, T. F., Parkes, M., & Smith, K. G. C.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Smith, Kenneth G.C.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2011-10-03
- Volume
- 121
- Issue
- 10
- Pages
- 4170-4179
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3196314
- OpenAlex
- W2015008025
- Cited by
- 304
- References
- 58
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 15 · 2023: 30 · 2022: 29 · 2021: 27 · 2020: 28 · 2019: 40 · 2018: 10 · 2017: 18 · 2016: 21 · 2015: 22 · 2014: 17 · 2013: 16 · 2012: 17
- FWCI
- 10.18
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Wellcome Trust (083650/Z/07/Z, 079895/Z/06/Z, 079895, 079895/Z/06/B)
- Crohn's and Colitis UK (M09-2)
- Medical Research Council
- Cambridge Institute for Medical Research, University of Cambridge (079895)
- NIHR Cambridge Biomedical Research Centre
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- Crohn's disease, ulcerative colitis, inflammatory bowel disease, CD8+ T cells, gene expression profiling, prognostic factors, recurrence, IL-7 signaling, T cell receptor signaling, CD4+ T cells, personalized treatment
- MeSH terms
- Adult, Colitis, Ulcerative, Crohn Disease, Female, Humans, Male, Middle Aged, Prognosis, Prospective Studies, Receptors, Antigen, T-Cell, Signal Transduction, Interleukin-7, CD8-Positive T-Lymphocytes, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.